Strom B L, Melmon K L
JAMA. 1979 Nov 30;242(22):2420-2.
Postmarketing drug surveillance (PMS) assesses the epidemiology of drug use and monitors beneficial or harmful effects of drugs following marketing. If used systematically, PMS can substantially improve drug therapy in the United States. This can be accomplished by generating information on drug use and effects otherwise unavailable, by enabling a more efficient drug approval process, and by educating drug prescribers. However, to be successful, any PMS system will need a good deal of input from such prescribers.
上市后药物监测（PMS）评估药物使用的流行病学情况，并监测药物上市后的有益或有害影响。如果系统地使用，PMS可以大幅改善美国的药物治疗。这可以通过生成关于药物使用和效果的信息（否则这些信息无法获得）、通过实现更高效的药物审批过程以及通过教育药物开处方者来实现。然而，要取得成功，任何PMS系统都需要来自此类开处方者的大量投入。
